EVEREST II
2011
Endovascular Valve Edge-to-Edge Repair Study II
In 279 patients with grade 3+/4+ mitral regurgitation, percutaneous MitraClip repair was less effective at reducing death, mitral surgery, or residual MR at 12 months but safer than mitral valve surgery.
Result
- Absolute difference
- 18 points
- NNH
- 6
Absolute difference and NNH are derived from the event rates.
Also reported: Surgery more effective), but MitraClip had far fewer 30-day major adverse events (15% vs 48%, P<0.001).
- Subtopic
- MitraClip
- Design
- Multicentre RCT (2:1), non-inferiority for efficacy
- Relevance
- Supporting: context rather than must-know.
- Cited in
- ACC/AHA 2020 VHD
- Source
- Feldman T, et al. N Engl J Med. 2011;364(15):1395-1406.doi 10.1056/NEJMoa1009355
Discussion & critique
Enrolled mostly degenerative MR in good surgical candidates, and residual MR common with the clip. Established MitraClip as safer but less durable, positioning it for high-risk primary MR and later functional MR (COAPT).